Contraception: latest news

Contraception resources

  • Emergency contraception and unwanted pregnancy

    For women taking HIV treatment, the intrauterine device (IUD) is the recommended method of emergency contraception.Women taking some anti-HIV drugs need to take a double dose of...

    From: Factsheets

    Information level Level 2
  • Contraception

    Your choice of contraception will depend on your situation and preferences.There are possible interactions between some hormonal contraceptives and some anti-HIV drugs. Your HIV treatment needs to be...

    From: Factsheets

    Information level Level 2
  • Contraception, conception and pregnancy

    Becoming a parent of a healthy, HIV-negative child is now a very realistic option for many people with HIV. However, you may want to plan when pregnancy...

    From: Booklets

    Information level Level 2
  • Condoms

    Condoms protect against HIV, other sexually transmitted infections and pregnancy.Both female and male condoms are available.It’s important to follow the advice on how to use...

    From: Factsheets

    Information level Level 2
  • Contraception

    Contraception is a way to prevent pregnancy. This allows you to plan a pregnancy for a time when you’re ready to have a child or to avoid...

    From: Booklets

    Information level Level 2
  • HIV treatment, pregnancy and contraception

    When HIV treatment is used during pregnancy, it protects your health as well as playing an important role in preventing HIV being passed on from you to...

    From: Booklets

    Information level Level 2
  • HIV & Contraception

    ...

    From: Resources

Contraception features

Contraception news from aidsmap

More news

Contraception news selected from other sources

  • Guidelines for the sexual and reproductive health of people living with HIV - consultation open

    These BHIVA / BASHH / FSRH guidelines are an update to the 2007 UK guidelines for the management of sexual and reproductive health (SRH) of people living with HIV infection (PLWH). They are open for consultation to Friday 8 December 2017.

    13 October 2017 | BHIVA
  • South Africa: Parents, principals will no longer decide whether pupils access condoms at schools

    School governing bodies and parents will no longer be able to prevent pupils from getting condoms at schools, according to a new basic education department policy released on Wednesday.

    14 June 2017 | Bhekisisa
  • Taking Birth Control With HIV Treatment or PrEP Is Largely OK

    Women taking various forms of hormonal contraceptives can likely combine them safely with antiretrovirals (ARVs), whether as HIV treatment or in the form of Truvada (tenofovir disoproxil fumarate/emtricitabine) as pre-exposure prophylaxis (PrEP) against the virus. The one ARV that may be problematic to combine with such forms of birth control is Sustiva (efavirenz), which is included in Atripla (efavirenz/tenofovir disoproxil fumarate/emtricitabine).

    30 May 2017 | Poz
  • HIV, family planning groups grapple with new WHO guidance on popular contraceptive

    The World Health Organization's reclassification last month of progestogen-only injectable contraceptives has triggered a critical debate in the family planning community over how to manage the potential link between higher rates of HIV acquisition and one of the most popular birth control methods in many at-risk communities.

    04 April 2017 | Devex
  • Statement by the ECHO Management Committee on the new WHO guidance on use of hormonal contraceptives by women at high risk of HIV

    Injectable progestogens are the most widely used contraceptives in sub-Saharan Africa, including in countries with high HIV prevalence. On 2 March 2017, the World Health Organisation (WHO) released revised guidance on the use of hormonal contraceptives by women at high risk of HIV infection.

    06 March 2017 | Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study
  • Hormonal contraceptive eligibility for women at high risk of HIV: Guidance Statement

    The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was recognized as a critical one, particularly for sub-Saharan Africa, where women have a high lifetime risk of acquiring HIV, hormonal contraceptives constitute a significant component of the contraceptive method mix and unintended pregnancy is a common threat to the well-being and lives of women and girls.

    03 March 2017 | WHO
  • Vaginal Ring Form of PrEP Does Not Reduce Contraceptive Effectiveness

    The antiretroviral (ARV)-containing vaginal ring form of pre-exposure prophylaxis (PrEP) that reduced HIV risk in a major trial does not lower the effectiveness of hormonal birth control. This finding assuages concerns raised by previous research that the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of ARVs has been associated with a lowered effectiveness of some hormonal contraceptives.

    16 February 2017 | Poz
  • The Mexico City Policy: An Explainer

    On January 23, President Donald Trump reinstated the Mexico City Policy via presidential memorandum. The policy requires foreign non-governmental organizations (NGOs) to certify that they will not “perform or actively promote abortion as a method of family planning,” using funds from any source (including non-U.S. funds), as a condition for receiving U.S. government global family planning assistance and, as of Jan. 23, 2017, any other U.S. global health assistance.

    24 January 2017 | Kaiser Family Foundation
  • Trump Strikes at Abortion With a Revived Foreign-Aid Rule

    The president has reinstated a contentious policy that blocks funding to international family-planning organizations unless they agree not to promote abortion.

    23 January 2017 | The Atlantic
  • Hormonal contraception and the risk of HIV acquisition in women

    The World Health Organization will convene an expert review group later in 2016 to examine the links between the use of various hormonal contraceptive methods and women’s risk of HIV acquisition. The expert review group will assess whether current WHO guidance needs to change in the light of a new review of data, published in AIDS on 9 August 2016, which was commissioned by WHO.

    15 August 2016 | World Health Organization
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.